Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
AGN-193408 SR by AbbVie for Ocular Hypertension: Likelihood of Approval
AGN-193408 SR is under clinical development by AbbVie and currently in Phase II for Ocular Hypertension. According to GlobalData, Phase...
Data Insights
AGN-193408 SR by AbbVie for Open-Angle Glaucoma: Likelihood of Approval
AGN-193408 SR is under clinical development by AbbVie and currently in Phase II for Open-Angle Glaucoma. According to GlobalData, Phase...